Get started
Author

Machiko Kawaguchi

Institution: Kurume University
Observed institution: Kurume University
ORCID: 0009-0008-3117-4448
Observed ORCID: 0009-0008-3117-4448
OpenAlex ID: A5045338176
Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction‐associated steatotic liver disease
2024 · Masahito Nakano, Machiko Kawaguchi, et al. · Hepatology Research · 33
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
2022 · Saori Takamura, Yuichi Teraki, et al. · Clinical and Molecular Hepatology · 33
PDF
Almost identical values of various non-invasive indexes for hepatic fibrosis and steatosis between NAFLD and MASLD in Asia
2024 · Masahito Nakano, Machiko Kawaguchi, et al. · Journal of Hepatology · 29
PDF
Hepatic expression of sodium–glucose cotransporter 2 (SGLT2) in patients with chronic liver disease
2022 · Dan Nakano, Jun Akiba, et al. · Medical Molecular Morphology · 28
PDF
Resistance exercise in combination with aerobic exercise reduces the incidence of serious events in patients with liver cirrhosis: a meta-analysis of randomized controlled trials
2023 · Takumi Kawaguchi, Atsushi Kawaguchi, et al. · Journal of Gastroenterology · 27
Changing from NAFLD to MASLD: The implications for health-related quality of life data
2024 · Ryuki Hashida, Dan Nakano, et al. · Journal of Hepatology · 25
PDF
The Inter-Organ Crosstalk Reveals an Inevitable Link between MAFLD and Extrahepatic Diseases
2023 · Tsubasa Tsutsumi, Dan Nakano, et al. · Nutrients · 25
PDF
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study
2023 · Tomoya Sano, Keisuke Amano, et al. · Hepatology Research · 24
MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men
2022 · Tsubasa Tsutsumi, Dan Nakano, et al. · Diabetology & Metabolic Syndrome · 24
PDF
Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
2024 · Hiroyuki Suzuki, Tsubasa Tsutsumi, et al. · Clinical and Molecular Hepatology · 21
PDF
Metabolic dysfunction‐associated fatty liver disease directly related to liver fibrosis independent of insulin resistance, hyperlipidemia, and alcohol intake in morbidly obese patients
2022 · Susumu Inamine, Masayoshi Kage, et al. · Hepatology Research · 19
A low‐intensity 10‐min resistance exercise program that ameliorated hepatic fibrosis indices and altered G‐CSF / IP ‐10/ PDGF‐BB in a patient with nonalcoholic fatty liver disease: A case report
2023 · Ryuki Hashida, Dan Nakano, et al. · JGH Open · 7
Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
2024 · Tsubasa Tsutsumi, Dan Nakano, et al. · Clinical and Molecular Hepatology · 6
PDF
Meaningful word acquisition is associated with walking ability over 10 years in Rett syndrome
2020 · Tomoko Saikusa, Machiko Kawaguchi, et al. · Brain and Development · 5
PDF
The Effect of MAFLD on Hepatocarcinogenesis in HBeAg-negative Patients with Undetectable HBV-DNA under NA Therapy: A Multicenter Study
2025 · Keisuke Amano, Tomoya Sano, et al. · Internal Medicine · 4
PDF
Equivalent prevalence and progression of chronic kidney disease in non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
2024 · Hiroyuki Suzuki, Tsubasa Tsutsumi, et al. · Clinical and Molecular Hepatology · 4
Effects of eplerenone on blood pressure and glucose metabolism in Japanese hypertensives with overweight or obesity
2019 · Hisashi Adachi, Tatsuyuki Kakuma, et al. · Medicine · 4
Fast score is associated with patient-reported outcomes in patients with metabolic dysfunction-associated steatotic liver disease
2024 · Ryuki Hashida, Takumi Kawaguchi, et al. · European Journal of Gastroenterology & Hepatology · 3
Nationwide Trends in Liver Stiffness Measurement in Japan: A Real‐World Evidence of NILDA Using the National Database of Health Insurance Claims
2025 · Masahito Nakano, Machiko Kawaguchi, et al. · Hepatology Research · 2
Regional Difference of Liver Cancer in Japan: A Real-world Evidence Using the National Database of Health Insurance Claims
2025 · Masahito Nakano, Machiko Kawaguchi, et al. · Internal Medicine · 2
PDF
[A Super-Elderly Patient with Recurrent Colon Cancer with Metastasis Effectively Treated with Capecitabine plus Bevacizumab Chemotherapy-A Case Report].
2018 · Satoshi Matsui, Daisuke Kajiyama, et al. · PubMed · 1
An Association of Covert Hepatic Encephalopathy with Non-elderly and MASLD in Patients with Chronic Liver Disease: Data-mining Analyses
2026 · Dan Nakano, Yui Yamaguchi, et al. · Internal Medicine
PDF
A case of hypovascular hepatic lesion with suspected clonorchiasis
2025 · Masahito Nakano, Machiko Kawaguchi, et al. · Clinical Journal of Gastroenterology
Improvement of Frailty with Rehabilitation therapy in a patient with alcohol-related decompensated liver cirrhosis
2024 · Shunji Koya, Dan Nakano, et al. · Kanzo
PDF
[Case of Peritoneal Dissemination from Gastrointestinal Stromal Tumor of Jejunum Treated with Repeated Non-Curative Surgery].
2020 · Hidetoshi Amagasa, Katsunori Ami, et al. · PubMed
Works count: 27
Citation count: 326
H-index: 11
I10-index: 11
Year
Topic
Type